NET PROFIT (x1000 DKK)
EMPLOYEES
Wilson Therapeutics AB
Closing information (x1000 DKK)
| Closing information | 2020/12 | 2019/12 | 2018/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
652,940
|
1,621
|
2,449 |
| Earnings before taxes |
-502,280
|
4,824,694
|
-284,254 |
| EBITDA |
-620
|
4,766,830
|
-292,216 |
| Total assets |
4,774,272
|
9,316,264
|
58,671 |
| Current assets |
4,774,197
|
9,315,213
|
10,398 |
| Current liabilities |
49,699
|
4,267,363
|
32,456 |
| Equity capital |
4,724,572
|
5,048,901
|
26,118 |
| - share capital |
2,330
|
2,251
|
2,285 |
| Employees (average) |
0
|
1
|
14 |
Financial ratios
| Fiscal year | 2020/12 | 2019/12 | 2018/12 |
| Solvency |
99.0%
|
54.2%
|
44.5% |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
3.2%
|
51.8%
|
-480.3% |
| Current ratio |
9606.2%
|
218.3%
|
32.0% |
| Return on equity (ROE) |
-10.6%
|
95.6%
|
-1088.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
-13
|
0 |
| Chg. No. of employees % |
-100%
|
-93% |
Total value of public sale
| Fiscal year | 2020/12 | 2019/12 | 2018/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.